about
The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptomsQuinidine as a probe for CYP3A4 activity: intrasubject variability and lack of correlation with probe-based assays for CYP1A2, CYP2C9, CYP2C19, and CYP2D6.Fluvoxamine inhibits the CYP2C9 catalyzed biotransformation of tolbutamide.Variants in Pharmacokinetic Transporters and Glycemic Response to Metformin: A Metgen Meta-Analysis.The Pharmacogenetics of Tacrolimus in Corticosteroid-Sparse Pediatric and Adult Kidney Transplant Recipients.CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: a first step towards subpopulation-specific dosages.Dextropropoxyphene kinetics after single and repeated oral doses in man.Escitalopram is a weak inhibitor of the CYP2D6-catalyzed O-demethylation of (+)-tramadol but does not reduce the hypoalgesic effect in experimental pain.Intake of St John's wort improves the glucose tolerance in healthy subjects who ingest metformin compared with metformin alone.Some aspects of genetic polymorphism in the biotransformation of antidepressants.Pharmacokinetic interaction between amprenavir and delavirdine after multiple-dose administration in healthy volunteers.The impact of CYP2C8 polymorphism and grapefruit juice on the pharmacokinetics of repaglinide.The effects of human CYP2C8 genotype and fluvoxamine on the pharmacokinetics of rosiglitazone in healthy subjects.Effect of diclofenac, disulfiram, itraconazole, grapefruit juice and erythromycin on the pharmacokinetics of quinidine.Phenotypes and genotypes for CYP2D6 and CYP2C19 in a black Tanzanian population.Tacrine is not an ideal probe drug for measuring CYP1A2 activity in vivoThe CYP2D6 polymorphism in relation to the metabolism of amitriptyline and nortriptyline in the Faroese populationNeurotoxicity and low paclitaxel clearance associated with concomitant clopidogrel therapy in a 60-year-old Caucasian woman with ovarian carcinomaPharmacogenomics and migraine: possible implications.Pharmacogenetics of drug oxidation via cytochrome P450 (CYP) in the populations of Denmark, Faroe Islands and Greenland.The Pharmacogenetics of Tramadol.A Comprehensive Review of Drug-Drug Interactions with Metformin.Genetic Polymorphisms in Organic Cation Transporter 1 Attenuates Hepatic Metformin Exposure in Humans.Clopidogrel-Paclitaxel Drug-Drug Interaction: A Pharmacoepidemiologic Study.Clinical Pharmacology in Denmark in 2016 - 40 Years with the Danish Society of Clinical Pharmacology and 20 Years as a Medical Speciality.Lack of genetic association between OCT1, ABCB1, and UGT2B7 variants and morphine pharmacokinetics.Imipramine and pregabalin combination for painful polyneuropathy: a randomized controlled trial.A candidate gene study of serotonergic pathway genes and pain relief during treatment with escitalopram in patients with neuropathic pain shows significant association to serotonin receptor2C (HTR2C).Escitalopram in painful polyneuropathy: a randomized, placebo-controlled, cross-over trial.Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial.In Vivo Imaging of Human 11C-Metformin in Peripheral Organs: Dosimetry, Biodistribution, and Kinetic Analyses.Limited sampling strategy for determining metformin area under the plasma concentration-time curve.Impact of ABCB1 variants on neutrophil depression: a pharmacogenomic study of paclitaxel in 92 women with ovarian cancer.Role of cytochrome P450 2C8*3 (CYP2C8*3) in paclitaxel metabolism and paclitaxel-induced neurotoxicity.The ABCB1, rs9282564, AG and TT Genotypes and the COMT, rs4680, AA Genotype are Less Frequent in Deceased Patients with Opioid Addiction than in Living Patients with Opioid Addiction.Drug metabolism and genetic polymorphism in subjects with previous halothane hepatitis.Griseofulvin and fluvoxamine interactions with the metabolism of theophylline.Impact of quinidine on plasma and cerebrospinal fluid concentrations of codeine and morphine after codeine intake.Open letter on access to the BIA 10-2474 clinical trial data.Systemic uptake of miconazole during vaginal suppository use and effect on CYP1A2 and CYP3A4 associated enzyme activities in women.
P50
Q28330096-346DE5D8-CA3B-4179-8277-91477C0EFD13Q31439293-987E5B51-EC06-4B09-A11C-4FE1D8C54682Q31945955-706DF4A2-2D36-47CE-98F8-326DC314B05BQ33658321-B2BA0EB8-CE13-4608-9C8F-EAC1E3EC977CQ33665154-C05CAF05-CD3E-4EE0-AB6B-9B98CD326093Q34352560-DBA5DA86-27DB-41FC-AA22-4B3EDC714E99Q34695756-0714F9A8-2897-481A-904B-016D077E0383Q34999764-A18846D4-9CC2-4F51-9427-B0BA37F45C49Q35023736-5DE0EC6B-19AA-4A35-AD7E-198CEBDAF100Q35806785-79D2DA51-FAC2-4351-8029-5F59E0A35305Q35825158-3F793790-17F6-47ED-890B-80E8E17DC3DBQ35827353-CD5C9C99-42E5-46D3-B971-6E9595D704CDQ35827919-6C1A8E89-32F9-4795-8FB6-F59524087F2BQ36053651-19E5B322-87D3-4B4C-BD7C-588315CF099DQ36053715-8A9A06C5-9639-48CB-A248-613D41404AE4Q36053773-F74BF960-0072-4D0F-A113-457813BBE54AQ36536020-D9AAA77A-B675-46DE-8679-01704D195877Q36802118-EA338F40-A78E-48A7-992E-69C8AD82B122Q37064080-CE87F6F5-BE03-4052-86D5-F2A2EC296E90Q38365410-3F0FDFA3-4EC3-4172-B509-E306EAA8F5D9Q38441114-9625B4BD-FA18-4E63-8ED0-C44D416AB6D0Q38460322-C350841E-AE4A-4D07-9147-5F819B520254Q38852147-BB4DD382-1493-4533-B2B0-58CF255A4499Q38948699-36E6E31E-8A2C-4541-A24B-18C063DDD7C2Q38967948-D5D534E1-7D8E-4B10-BF30-2E54D3A62A67Q39034109-F6934A61-1789-44CB-94E9-314EB59728C2Q39193489-F58289B4-9264-44F7-A21A-52EAD132BBD9Q39265337-FB6E4872-7B04-4FCD-83E8-D0BE1C98797FQ39318526-AC2F6BAE-E498-4B38-BDFC-41C5BCF08291Q39436068-5F6B0158-2FE4-4F25-8365-52F8EDEC07D9Q39548900-D589ADD3-7E1D-49FE-AA5D-D048DCABF7B0Q39669192-3FBB5F2B-6569-4C4C-9015-ED7D8C263DFBQ39702921-81C34401-E180-4C84-B0AA-331C7337EA40Q40793437-2078EB35-0B8B-496C-A754-8CD2E95BBB78Q40809567-06187A84-E4D8-4E25-A55C-3F4FE2A88814Q42286097-7B024701-7F90-49F7-88E7-C93AA845746EQ42551200-BBF2DCA8-263D-41EE-A367-F79B42EA52BCQ42555336-57F30703-331D-47EB-959D-0EDD09B3489BQ42632062-D60CAA30-5458-4B1C-9CFB-A78C4A7C68D1Q42868963-3C904139-818A-42EB-A672-F4043E776500
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Kim Brosen
@ast
Kim Brosen
@en
Kim Brosen
@es
Kim Brosen
@nl
Kim Brosen
@sl
type
label
Kim Brosen
@ast
Kim Brosen
@en
Kim Brosen
@es
Kim Brosen
@nl
Kim Brosen
@sl
altLabel
Kim Broesen
@en
Kim Brøsen
@en
prefLabel
Kim Brosen
@ast
Kim Brosen
@en
Kim Brosen
@es
Kim Brosen
@nl
Kim Brosen
@sl
P214
P244
P1053
F-6023-2011
P106
P1153
7005953102
P214
P244
P31
P3829
P496
0000-0001-8444-7835
P735
P7859
lccn-n00003759